Vivos Therapeutics gets FDA clearance for sleep apnea treatment device

Medical technology company Vivos Therapeutics received FDA 510(k) clearance for its daytime-nighttime device to treat obstructive sleep apnea.

Vivos Therapeutics develops treatments for dentofacial abnormalities, mild-to-moderate obstructive sleep apnea and snoring in adults.

The device expands the palate to open the airway and facilitate nasal breathing, according to a Jan. 4 news release. It is Vivos' longest standing appliance and is used most among its trained dentists. The device can also be used in conjunction with other treatment modalities.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.